ctrl K

Watchlist Price Alert

Intelligent Medicine Acqu... (IQMDW)

NASDAQ: IQMDW · Real-Time Price · USD

0.00

-0.03 (-100.00%)

At close: Sep 17, 2024, 8:00 PM

Intelligent Medicine Acquisition Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021
Period Ending	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	4,366.1B	4,366.1B	4,366.1B	4,366.1B	-20.9K	-20.9K	-20.83K
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	4,366.1B	4,366.1B	4,366.1B	4,366.1B	-20.83K	-20.83K	-20.83K
Net Income	4,366.1B	4,366.1B	4,366.1B	4,366.1B	-20.83K	-20.83K	-20.83K
Selling & General & Admin	295.82B	295.82B	295.82B	295.82B	20.9K	20.9K	20.83K
Research & Development	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	n/a	n/a	-150	-150	-150	-150	n/a
Operating Expenses	295.82B	295.82B	295.82B	295.82B	20.75K	20.75K	20.83K
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	295.82B	295.82B	295.82B	295.82B	20.75K	20.75K	20.83K
Income Tax Expense	502.11K	215.45K	-51.79K	-116.27K	-55.81K	-55.81K	-55.81K
Shares Outstanding (Basic)	5.17M	25.88M	25.88M	20.7M	28.35M	25.88M	25.88M
Shares Outstanding (Diluted)	5.17M	25.88M	25.88M	20.7M	28.35M	25.88M	25.88M
EPS (Basic)	210.92K	210.92K	210.92K	210.92K	-0.00	-0.00	-0.00
EPS (Diluted)	210.92K	210.92K	210.92K	210.92K	-0.00	-0.00	-0.00
EBITDA	4,366.1B	4,366.1B	4,366.1B	4,366.1B	-20.9K	-20.9K	-20.83K
EBIT	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	228.49K	245K	271.92K	241.66K	181.2K	109.81K	55.81K